Peters J H, Ginsberg M H, Bohl B P, Sklar L A, Cochrane C G
J Clin Invest. 1986 Dec;78(6):1596-603. doi: 10.1172/JCI112752.
Fibronectin (Fn) is produced by cells in blood vessels at inflammatory sites in vivo. Fn release into the circulation thus may be a marker for vascular injury. In support of this, we found that oxidant-induced vascular injury of isolated perfused rabbit lungs caused elevated circulating Fn levels. Western blot analysis indicated that Fn released from the injured blood vessels was intact, dimeric, and possessed electrophoretic mobility identical with Fn produced by fibroblasts. Unlike Fn isolated from rabbit plasma, Fn derived from lung perfusate or produced by fibroblasts reacted with antibodies raised to a synthetic peptide containing sequences from the extra type III Fn domain that is transcribed in fibroblasts but not hepatocytes. Vascular injury by protease was also associated with intravascular release of Fn, but with cleavage. Oxidant-induced vascular injury causes release of tissue-derived Fn, which can be distinguished from plasma Fn by its size and content of antigenic determinants of the extra type III domain.
纤连蛋白(Fn)由体内炎症部位血管中的细胞产生。因此,Fn释放到循环系统中可能是血管损伤的一个标志物。支持这一观点的是,我们发现氧化剂诱导的离体灌注兔肺血管损伤会导致循环中Fn水平升高。蛋白质免疫印迹分析表明,从受损血管释放的Fn是完整的二聚体,其电泳迁移率与成纤维细胞产生的Fn相同。与从兔血浆中分离出的Fn不同,源自肺灌注液或由成纤维细胞产生的Fn能与针对含额外III型Fn结构域序列的合成肽产生的抗体发生反应,该结构域在成纤维细胞而非肝细胞中被转录。蛋白酶引起的血管损伤也与血管内Fn释放有关,但会发生裂解。氧化剂诱导的血管损伤会导致组织源性Fn的释放,其可以通过大小和额外III型结构域抗原决定簇的含量与血浆Fn区分开来。